PDE4A and chronic bronchitis: In a recent post-hoc analysis of the BIOMARKER study (Table 4) focused on sputum gene expression it was shown that patients with chronic bronchitis and higher sputum eosinophil counts on treatment with triple therapy had increased expression of type-2 and PDE4 related genes (Singh et al., 2020b).